Cargando…

COVID-19 spike-host cell receptor GRP78 binding site prediction

OBJECTIVES: Understanding the novel coronavirus (COVID-19) mode of host cell recognition may help to fight the disease and save lives. The spike protein of coronaviruses is the main driving force for host cell recognition. METHODS: In this study, the COVID-19 spike binding site to the cell-surface r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Ibrahim M., Abdelmalek, Doaa H., Elshahat, Mohammed E., Elfiky, Abdo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102553/
https://www.ncbi.nlm.nih.gov/pubmed/32169481
http://dx.doi.org/10.1016/j.jinf.2020.02.026
_version_ 1783511852818366464
author Ibrahim, Ibrahim M.
Abdelmalek, Doaa H.
Elshahat, Mohammed E.
Elfiky, Abdo A.
author_facet Ibrahim, Ibrahim M.
Abdelmalek, Doaa H.
Elshahat, Mohammed E.
Elfiky, Abdo A.
author_sort Ibrahim, Ibrahim M.
collection PubMed
description OBJECTIVES: Understanding the novel coronavirus (COVID-19) mode of host cell recognition may help to fight the disease and save lives. The spike protein of coronaviruses is the main driving force for host cell recognition. METHODS: In this study, the COVID-19 spike binding site to the cell-surface receptor (Glucose Regulated Protein 78 (GRP78)) is predicted using combined molecular modeling docking and structural bioinformatics. The COVID-19 spike protein is modeled using its counterpart, the SARS spike. RESULTS: Sequence and structural alignments show that four regions, in addition to its cyclic nature have sequence and physicochemical similarities to the cyclic Pep42. Protein-protein docking was performed to test the four regions of the spike that fit tightly in the GRP78 Substrate Binding Domain β (SBDβ). The docking pose revealed the involvement of the SBDβ of GRP78 and the receptor-binding domain of the coronavirus spike protein in recognition of the host cell receptor. CONCLUSIONS: We reveal that the binding is more favorable between regions III (C391-C525) and IV (C480-C488) of the spike protein model and GRP78. Region IV is the main driving force for GRP78 binding with the predicted binding affinity of -9.8 kcal/mol. These nine residues can be used to develop therapeutics specific against COVID-19.
format Online
Article
Text
id pubmed-7102553
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71025532020-03-31 COVID-19 spike-host cell receptor GRP78 binding site prediction Ibrahim, Ibrahim M. Abdelmalek, Doaa H. Elshahat, Mohammed E. Elfiky, Abdo A. J Infect Article OBJECTIVES: Understanding the novel coronavirus (COVID-19) mode of host cell recognition may help to fight the disease and save lives. The spike protein of coronaviruses is the main driving force for host cell recognition. METHODS: In this study, the COVID-19 spike binding site to the cell-surface receptor (Glucose Regulated Protein 78 (GRP78)) is predicted using combined molecular modeling docking and structural bioinformatics. The COVID-19 spike protein is modeled using its counterpart, the SARS spike. RESULTS: Sequence and structural alignments show that four regions, in addition to its cyclic nature have sequence and physicochemical similarities to the cyclic Pep42. Protein-protein docking was performed to test the four regions of the spike that fit tightly in the GRP78 Substrate Binding Domain β (SBDβ). The docking pose revealed the involvement of the SBDβ of GRP78 and the receptor-binding domain of the coronavirus spike protein in recognition of the host cell receptor. CONCLUSIONS: We reveal that the binding is more favorable between regions III (C391-C525) and IV (C480-C488) of the spike protein model and GRP78. Region IV is the main driving force for GRP78 binding with the predicted binding affinity of -9.8 kcal/mol. These nine residues can be used to develop therapeutics specific against COVID-19. The British Infection Association. Published by Elsevier Ltd. 2020-05 2020-03-10 /pmc/articles/PMC7102553/ /pubmed/32169481 http://dx.doi.org/10.1016/j.jinf.2020.02.026 Text en © 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Ibrahim, Ibrahim M.
Abdelmalek, Doaa H.
Elshahat, Mohammed E.
Elfiky, Abdo A.
COVID-19 spike-host cell receptor GRP78 binding site prediction
title COVID-19 spike-host cell receptor GRP78 binding site prediction
title_full COVID-19 spike-host cell receptor GRP78 binding site prediction
title_fullStr COVID-19 spike-host cell receptor GRP78 binding site prediction
title_full_unstemmed COVID-19 spike-host cell receptor GRP78 binding site prediction
title_short COVID-19 spike-host cell receptor GRP78 binding site prediction
title_sort covid-19 spike-host cell receptor grp78 binding site prediction
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102553/
https://www.ncbi.nlm.nih.gov/pubmed/32169481
http://dx.doi.org/10.1016/j.jinf.2020.02.026
work_keys_str_mv AT ibrahimibrahimm covid19spikehostcellreceptorgrp78bindingsiteprediction
AT abdelmalekdoaah covid19spikehostcellreceptorgrp78bindingsiteprediction
AT elshahatmohammede covid19spikehostcellreceptorgrp78bindingsiteprediction
AT elfikyabdoa covid19spikehostcellreceptorgrp78bindingsiteprediction